21st Conference on Retroviruses and Opportunistic Infections (CROI 2014) Boston, Massachusetts, USA - March 3-6, 2014

Research output: Contribution to journalArticlepeer-review

Abstract

The 21st Conference on Retroviruses and Opportunistic Infections (CROI) took place in Boston on March 3-6, 2014. A wide variety of important research in the field of HIV medicine and related disciplines was presented, including results from clinical trials of new antiretroviral drugs which are in development, as well as results from studies exploring new strategies of antiretroviral therapy, such as maintenance regimens without the use of nucleoside analogue reverse transcriptase inhibitors. The presentations of new anti-hepatitis C virus (HCV) therapies with high cure rates, short treatment duration and a favorable toxicity profile were the highlight of CROI 2014.

Original languageEnglish (US)
Pages (from-to)309-316
Number of pages8
JournalDrugs of the Future
Volume39
Issue number4
DOIs
StatePublished - Apr 2014

Keywords

  • Antiretroviral therapy
  • HCV infection
  • HIV infection
  • Nucleoside analogues
  • Reverse transcriptase inhibitors

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)

Fingerprint Dive into the research topics of '21<sup>st</sup> Conference on Retroviruses and Opportunistic Infections (CROI 2014) Boston, Massachusetts, USA - March 3-6, 2014'. Together they form a unique fingerprint.

Cite this